Medigrow goes global as MG Health

18th November 2019:  As it prepares for strategic global expansion, Medigrow Lesotho Limited has announced that it has changed the name of the business to MG Health Limited.  As a licenced cultivator and manufacturer of pharmaceutical grade cannabis extracts and products, MG Health is a leader in the Kingdom of Lesotho’s emerging medical cannabis industry.

MG Health CEO, Andre Bothma says, “As a rapidly scaling up enterprise, we have made great strides over the past two years.  Our path diverged some time ago from other Medigrow entities, and now as we enter a new era, we go forward as MG Health, a distinct global brand committed to supplying world-class medical cannabis products to our local and international clients.”

MG Health has both its cultivation and state-of-the-art processing facilities based 2000 metres above sea-level in the mountains of Lesotho, where clean air and pristine environment  ensure the growth of high quality plants. The best-practice production plant was set-up, and has always operated according to the Good Manufacturing Practices of the EU, and MG Health is preparing for certification in 2020.  This will make MG Health one of the very few EU GMP-compliant cultivation, extraction and processing cannabis operations worldwide, and the largest in the southern hemisphere for the medicinal and pharmaceutical markets. 

With its new office established in the UK, MG Health plans to drive ambitious growth in the developed markets where health and wellness are growing sectors, and where the business can meet the demands of informed consumers for product integrity and quality.

As a founding member of the PIA (Phekoane Industry Association) MG Health played  a vital role in helping to establish Lesotho as reputable source country for high quality, pharmaceutical grade, medical cannabis.  “We’re excited in this new phase to take the MG Health brand onto the global stage to represent the incredible quality that our company and our country can produce,” concludes Bothma.

Please contact us on our website for any further information.